Tag: Nevirapine

According to a 2023 NCBI publication, Nevirapine (NVP) is a non-nucleoside reverse transcriptase inhibitor crucial for treating HIV-1 infection. However, the acronym **NVP Tablet** can also refer to a combination medication for pregnancy-related nausea and vomiting, leading to confusion about its intended use and patient population.

Single-dose Nevirapine (NVP) given to a mother and infant can reduce mother-to-child HIV transmission, with some studies showing a reduction in viral load of over 50% [1.9.1]. But for patients and caregivers, a crucial question remains: What are the side effects of NVP Syrup?